The follow-up pivotal trial (METAOD006 / OPTIONS) enrolled a larger cohort and failed to replicate statistically significant weight loss, which led Metabolic Pharmaceuticals to halt the formal drug development program in 2007
Heart failure Therefore, Pan-ERR agonist studies reported improved ejection fraction, reduced fibrosis, stronger mitochondrial programs, and better survival in a pressure-overload model
Mood and mental clarity B12 supports neurotransmitter balance and reduces brain fog
Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you
The PGD will not cover administration of hydroxocobalamin for use as a diet or health supplement
Consult a Professional Do not disregard professional medical advice or delay in seeking it because of something you have read on this website